Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New data expected at lung-cancer conference on experimental drug combos
New data expected at lung-cancer conference on experimental drug combos
New data expected at lung-cancer conference on experimental drug combos
Submitted by
admin
on September 4, 2015 - 9:01am
Source:
Medical Marketing and Media
News Tags:
lung cancer
Opdivo
Yervoy
Bristol-Myers Squibb
tremelimumab
MEDI4736
AstraZeneca
Roche
atezolizumab
Headline:
New data expected at lung-cancer conference on experimental drug combos
Do Not Allow Advertisers to Use My Personal information
